Please ensure Javascript is enabled for purposes of website accessibility
top of page
N=1 Collaborative

Oxford-Harrington Rare Disease Centre named first global initiative for children with rare disease

November 24, 2023


In the autumn statement on Wednesday 22 November, the government announced its support for the Rare Therapies Launch Pad, a new programme that will develop regulatory pathways for children with rare conditions to access individualised therapies.


The Oxford-Harrington Rare Disease Centre (OHC) in the Department of Paediatrics has a central role in the delivery of this programme, alongside Genomics England, the Association of the British Pharmaceutical Industry and the Medicines and Healthcare Regulatory Agency.


Tens of millions of children globally, including hundreds of thousands in the UK, have rare and life-threatening genetic diseases, with a very small number having access to a treatment. This announcement offers the prospect of change: new individualised therapeutic options are being created but there is currently no route to access these individualised medicines for most patients.

The Launch Pad aims to deliver an end-to-end pathway covering diagnosis, the design and rapid manufacturing of these therapies and treatment.



ree

The programme’s first project will explore the use of individualised therapies called antisense oligonucleotides (ASOs) to treat children with ultra-rare and life-threatening brain conditions. This approach has been driven by Julia Vitarello, mother of Mila, and founder of Mila’s Miracle Foundation. Mila was the first person to receive an individualised medicine, an ASO called Milasen, for a condition called Batten’s disease. Longer term, the Rare Therapies Launch Pad will support access to other types of individualised therapies across a wider range of rare conditions, which affect 1 in 17 people globally.




Oxford-Harrington Rare Disease Centre named in first global. University of Oxford. (n.d.). https://www.ox.ac.uk/news/2023-11-24-oxford-harrington-rare-disease-centre-named-first-global-initiative-children-rare

 
 
 

1 Comment


Azmi
Azmi
Sep 30

My husband was diagnosed with Creutzfeldt-Jakob Disease (CJD) four years ago. For over two years, we relied on prescription medications and therapies, but unfortunately, his symptoms continued to worsen. His memory, coordination, and overall strength declined, and everyday life became increasingly difficult.Last year, out of desperation and hope, we decided to try an herbal treatment program from NaturePath Herbal Clinic. Honestly, we were skeptical at first, but within a few months of starting the treatment, we began to notice real changes. His alertness improved, his movements became steadier, and he regained a surprising amount of energy and clarity.Incredibly, he also regained much of his independence and confidence. It’s been a life-changing experience he feels more like himself again, better than…

Like

Join Our Community List

Relationship Required
Area(s) of Interest Required

Thanks for submitting!

N=1 Collaborative

Contact Us

501c3 Nonprofit Organization

EIN: 88-2591503

©2024 by N=1 Collaborative

Crafted By: Finfrock Marketing

bottom of page